Trifluoroacetic acid → HCID 44442357, compound
Reaction equation
[NH:1]([C:8](=[O:43])[C:9]([C:20]1[CH:42]=[CH:41][C:23]([C:24]([NH:26][C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=2[NH:33]C(=O)OC(C)(C)C)=[O:25])=[CH:22][CH:21]=1)([C:11]([NH:13][C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1)=[O:12])[CH3:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.FC(F)(F)C(O)=O>C(Cl)Cl>[NH2:33][C:28]1[CH:29]=[CH:30][CH:31]=[CH:32][C:27]=1[NH:26][C:24]([C:23]1[CH:41]=[CH:42][C:20]([C:9]([CH3:10])([C:8]([NH:1][C:2]2[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=2)=[O:43])[C:11]([NH:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[O:12])=[CH:21][CH:22]=1)=[O:25]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of tert-butyl [2-({4-[2-anilino-1-(anilinocarbonyl)-1-methyl-2-oxoethyl]benzoyl}amino)phenyl]-carbamate (14 mg, 0.024 mmol) in CH2Cl2 (3 mL) at room temperature was added trifluoroacetic acid (1 mL). The reaction mixture was stirred at room temperature 30 min and concentrated. Purification by reverse phase HPLC (10% to 95% MeCN in water) gave 2-(4-{[(2-aminophenyl)amino]carbonyl}-phenyl)-2-methyl-N,N′-diphenylmalonamide (12 mg, TFA salt, 84%) as a white solid: 1H NMR (600 MHz, CDCl3) δ 9.77 (s br, 1H), 9.18 (s br, 2H), 7.87 (d, J=6.2 Hz, 21-1), 7.45-7.42 (m, 6H), 7.34-7.28 (m, 5H), 7.17-7.04 (m, 5H), 6.18 (s br, 21-1), 2.05 (s, 3H); ESIMS calcd 479.2 (M++H), found 479.2 (M++H).
Workup
- concentrationconcentrated
- customPurification by reverse phase HPLC (10% to 95% MeCN in water)
Sources & evidence
- ORD record
- ord-2e5b9bda011d4840be4b6788738c0308
- Source dataset
- uspto-grants-2012_04
- Patent number
- US08158825B2
Reaction notes
Loading…